Granite Announces $42 Million P-928 Relay Ground Station Project in Guam

WATSONVILLE, Calif.--(BUSINESS WIRE)-- Granite (NYSE: GVA) announced an approximately $42 million design-build contract by Naval Facilities Engineering Systems Command (NAVFAC) for a sitework and infrastructure project related to the Relay Ground Station-Asia (RGS-A) program at Naval Base Guam. Project funding is to come from federal sources and was included in Granite’s third-quarter backlog.

The project scope involves constructing four structures, multiple concrete foundations, and radar dome structures in support of the governments RGS-A program for the US space force. The RGS-A program is part of the U.S. Space Force's mission to update existing missile warning and missile defense systems with the Future Operationally Resilient Ground Evolution (FORGE) system.

“The project offers a chance to work with a strong existing client and build a strategic relationship for future projects within the planned Guam Missile Defense System,” said Curt Haldeman, Granite Vice President of Regional Operations.

Design began in September 2024, with construction expected to start January 2025 and be completed in August 2026.

Watch this video to learn more about our people and projects in Guam: Watch Now

About Granite

Granite is America’s Infrastructure Company™. Incorporated since 1922, Granite (NYSE: GVA) is one of the largest diversified construction and construction materials companies in the United States as well as a full-suite civil construction provider. Granite’s Code of Conduct and strong Core Values guide the Company and its employees to uphold the highest ethical standards. Granite is an industry leader in safety and an award-winning firm in quality and sustainability. For more information, visit the Granite website, graniteconstruction.com, and connect with Granite on LinkedIn, X, Facebook, and Instagram.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241030615380/en/

Media
Erin Kuhlman 831-768-4111
Investors
Wenjun Xu - 831-761-7861

Source: Granite

You May Also Be Interested In

• Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study
• CLARITY Act Vote Lands September 15, 6 Best Crypto Presales Ahead of Crypto’s Big Washington Test
• SURF'S UP FOR THE WORLD'S PAW-SOME-EST COMPETITORS!